Results 101 to 110 of about 3,412 (160)

The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review. [PDF]

Acta Neuropsychiatr
Raikkerus H, Bujour A, Kennedy M, Tiihonen J.   +3 more
europepmc   +1 more source

Novel Tetrahydropyridinyl-6,6-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches. [PDF]

ACS Med Chem Lett
Sabnis RW, Sabnis AR.
europepmc   +1 more source

Psychedelics and Autism Therapy: A Review of Current Research and Future Directions. [PDF]

Curr Issues Mol Biol
Gondi CS, Gnanamony M, Gondi TP, Nersesyan L, Demirkhanyan L.   +4 more
europepmc   +1 more source

Novel 6,5-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches. [PDF]

ACS Med Chem Lett
Sabnis RW, Sabnis AR.
europepmc   +1 more source

Filtering the noise: a cerebellar-centered framework for understanding and treating mental illness -a paradigm shift in psychiatry. [PDF]

Front Psychiatry
Ferris CF.
europepmc   +1 more source

Novel Compounds as 5‑HT2A Agonists for Treating Mental Illness or CNS Disorders. [PDF]

ACS Med Chem Lett
Sabnis RW, Sabnis AR.
europepmc   +1 more source

An international mega-analysis of psychedelic drug effects on brain circuit function. [PDF]

Nat Med
Girn M, Doss MK, Roseman L, Preller KH, Palhano-Fontes F, Pasquini L, Barrett FS, Mallaroni P, Mason NL, Timmermann C, McCulloch DE, Fisher PM, Winston BS, Moujaes F, Muller F, Liechti ME, Vollenweider FX, Ramaekers JG, Kuypers K, Araujo DB, Sporns O, Siegel J, Dosenbach N, Nutt DJ, Carhart-Harris RL, Stamatakis EA, Bzdok D.   +26 more
europepmc   +1 more source

Novel 5,6-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches. [PDF]

ACS Med Chem Lett
Sabnis RW, Sabnis AR.
europepmc   +1 more source

Simple Analogs of the LSD D-Ring: A Consideration of Structure-Activity Relationships and Their Potential as Therapeutics. [PDF]

ACS Chem Neurosci
Barker SA.
europepmc   +1 more source

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants. [PDF]

Clin Pharmacokinet
Mueller L, Klaiber A, Ley L, Becker AM, Thomann J, Luethi D, Schmid Y, Liechti ME.   +7 more
europepmc   +1 more source